The differing roles of PD-L1 in cervical tumors may originate from factors such as different PD-L1 antibodies and evaluation criteria, different subtypes of cervical carcinoma, and diverse ethnicities. This evidence concerns the gene CD274 and uterine cervix neoplasm.